Sagimet Biosciences (SGMT) Total Current Liabilities: 2023
Historic Total Current Liabilities for Sagimet Biosciences (SGMT) over the last 1 years, with Dec 2023 value amounting to $5.7 million.
- Sagimet Biosciences' Total Current Liabilities was N/A to $5.7 million in Q4 2023 from the same period last year, while for Dec 2023 it was $5.7 million, marking a year-over-year change of. This contributed to the annual value of $5.7 million for FY2023, which is N/A change from last year.
- Latest data reveals that Sagimet Biosciences reported Total Current Liabilities of $5.7 million as of FY2023.
- In the past 5 years, Sagimet Biosciences' Total Current Liabilities ranged from a high of $5.7 million in FY2023 and a low of $5.7 million during FY2023.
- Moreover, its 1-year median value for Total Current Liabilities was $5.7 million (2023), whereas its average is $5.7 million.